World’s first skin cancer vaccine offers hope for personalized cure [Video]

Doctors have commenced a global and final trial involving hundreds of patients for the world’s first personalized mRNA cancer vaccine. The vaccine is developed for melanoma, a skin cancer that affects more than 100,000 people per year. The trial is led by University College London Hospitals NHS Foundation Trust.

Dr. Heather Shaw highlighted the potential of the vaccine to offer a cure for individuals with melanoma. The vaccine is currently under examination for efficacy in treating other cancers, such as lung, bladder, and kidney. In a previous phase, the vaccine reduced the risk of the cancer returning in melanoma patients.

Uses the same Covid vaccine tech

The vaccine is named “mRNA-4157 (V940)”. It is neoantigen therapy, which triggers the immune system that hunts a …